Systémová enzymoterapie pro odborníky

Adjuvant Therapy with Hydrolytic Enzymes in Recurrent Laryngeal Papillomatosis

Juraj Mudrák¹, Ladislav Bobák² and Irina Šebová³

From the ¹Departments of Otorhinolaryngology, ²Immunology, P.J. Šafárik University Hospital, Košice, and ³1^st Department of Otorhinolaryngology, Comenius University Hospital, Bratislava, Slovak Republic

Acta Otolaryngol (Stockh) 1997; Suppl 527: 128 -130

314 KA (1-09-1)

The subject of- this study is systemic enzymotherapy as adjuvant treatment in recurrent laryngeal papillomatosis. The authors analyze their observations of 5 adult patients with recurrent laryngeal papillomatosis when after surgical extirpation and subsequent application of peroral proteases there was a significant improvement of their clinical state and laboratory results. The patients have been disease-free from 10 to 18 months. In the authors' experience, the adjuvant enzymotherapy seems to be a suitable replacement of the supplementary treatment in larynx papillomatosis, and it promises to decrease the recurrence rate as well.

Key words: recurrent laryngeal papillomatosis, hydrolytic emzymes, adjuvant therapy.


Úvod pro odborníky O firmě Kontakty Pomáháme druhým Poradna
Zánět a jeho ovlivnění SET Zvýšení využitelnosti antibiotik proteolytickými enzymy Angiologie, flebologie Diabetologie Gynekologie Chirurgie, traumatologie, ortopedie Imunologie Lymfologie ORL Pediatrie Revmatologie Sportovní medicína Stomatologie Urologie Literatura Časopisy s Impact faktorem Ostatní literatura SPC Wobenzym SPC Phlogenzym	Adjuvant Therapy with Hydrolytic Enzymes in Recurrent Laryngeal Papillomatosis Juraj Mudrák¹, Ladislav Bobák² and Irina Šebová³ From the ¹Departments of Otorhinolaryngology, ²Immunology, P.J. Šafárik University Hospital, Košice, and ³1^st Department of Otorhinolaryngology, Comenius University Hospital, Bratislava, Slovak Republic Acta Otolaryngol (Stockh) 1997; Suppl 527: 128 -130 314 KA (1-09-1) The subject of- this study is systemic enzymotherapy as adjuvant treatment in recurrent laryngeal papillomatosis. The authors analyze their observations of 5 adult patients with recurrent laryngeal papillomatosis when after surgical extirpation and subsequent application of peroral proteases there was a significant improvement of their clinical state and laboratory results. The patients have been disease-free from 10 to 18 months. In the authors' experience, the adjuvant enzymotherapy seems to be a suitable replacement of the supplementary treatment in larynx papillomatosis, and it promises to decrease the recurrence rate as well. Key words: recurrent laryngeal papillomatosis, hydrolytic emzymes, adjuvant therapy.
	Lék pro vnitřní užití. Čtěte pečlivě příbalovou informaci. Inzertní stránky společnosti MUCOS Pharma CZ, s.r.o. - tel: (+420)-267 750 003